Skip to content

Harrow HROW Inventories

Inventories at other companies

AbbVie logo
AbbVieABBV
$5.05B+11.6%
Bausch + Lomb logo
Bausch + LombBLCO
$977M-5.2%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$3.74M+14.3%
Viatris logo
ViatrisVTRS
$3.93B-4.1%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.53M-0.2%
PBH
Prestige Consumer HealthcarePBH
$159.13M+7.7%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's inventories?
Harrow (HROW) reported inventories of $16.5M in Q1 2026.
How has Harrow's inventories changed year-over-year?
Harrow's inventories increased by 53.9% year-over-year, from $10.72M to $16.5M.
What is the long-term trend for Harrow's inventories?
Over 5 years (2020 to 2025), Harrow's inventories has grown at a 27.8% compound annual growth rate (CAGR), from $3.96M to $13.52M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.